Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

M.D. Anderson Cancer Center · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
lymphodepleting chemotherapy, myeloid malignancies, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 981665
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.